Breaking News, Collaborations & Alliances

Translate Bio, AMRI Enter Manufacturing Agreement

Agreement provides Translate Bio with customized and dedicated manufacturing space for cGMP mRNA production for current and future programs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of medicines to treat diseases caused by protein or gene dysfunction, has entered into a multi-year strategic manufacturing agreement with Albany Molecular Research, Inc. (AMRI), a global clinical development manufacturing organization, in support of the planned expansion of Translate Bio’s current Good Manufacturing Practices (cGMP) clinical mRNA manufacturing capabilities.   Under the five-year agr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters